Feasibility trial of letrozole in combination with bevacizumab in patients with metastatic breast cancer Academic Article uri icon

Overview

MeSH Major

  • Antineoplastic Combined Chemotherapy Protocols
  • Breast Neoplasms
  • Lung Neoplasms
  • Soft Tissue Neoplasms

abstract

  • Combination letrozole and bevacizumab was feasible with expected bevacizumab-related events of hypertension, headache, and proteinuria. Phase III proof-of-efficacy trials of endocrine therapy plus bevacizumab are in progress (Cancer and Leukemia Group B 40503).

publication date

  • February 2010

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC3940895

Digital Object Identifier (DOI)

  • 10.1200/JCO.2009.21.8784

PubMed ID

  • 19841327

Additional Document Info

start page

  • 628

end page

  • 33

volume

  • 28

number

  • 4